115 related articles for article (PubMed ID: 8988459)
1. Early diagnosis in Parkinson's disease--limitation of biochemical markers and instrumental methods.
Kraus PH
J Neural Transm Suppl; 1996; 48():23-8. PubMed ID: 8988459
[TBL] [Abstract][Full Text] [Related]
2. [L-dopa-resistant Parkinson's disease with cerebral atrophy: striato-nigral degeneration?].
Dell'Aria V; Ciannella L; Melone MA
Acta Neurol Quad (Napoli); 1981; 42():212-5. PubMed ID: 7270052
[No Abstract] [Full Text] [Related]
3. Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome.
Bédard MA; Pillon B; Dubois B; Duchesne N; Masson H; Agid Y
Brain Cogn; 1999 Jul; 40(2):289-313. PubMed ID: 10413563
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic Parkinson's disease combined with multiple system atrophy. A clinicopathological report.
Hughes AJ; Daniel SE; Lees AJ
Mov Disord; 1991; 6(4):342-6. PubMed ID: 1758453
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages?
Hopes L; Grolez G; Moreau C; Lopes R; Ryckewaert G; Carrière N; Auger F; Laloux C; Petrault M; Devedjian JC; Bordet R; Defebvre L; Jissendi P; Delmaire C; Devos D
PLoS One; 2016; 11(4):e0147947. PubMed ID: 27035571
[TBL] [Abstract][Full Text] [Related]
6. Levodopa induces apoptosis in cultured neuronal cells--a possible accelerator of nigrostriatal degeneration in Parkinson's disease?
Ziv I; Zilkha-Falb R; Offen D; Shirvan A; Barzilai A; Melamed E
Mov Disord; 1997 Jan; 12(1):17-23. PubMed ID: 8990049
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?
Ling H; Kearney S; Yip HL; Silveira-Moriyama L; Revesz T; Holton JL; Strand C; Davey K; Mok KY; Polke JM; Lees AJ
J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):633-41. PubMed ID: 26209716
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of neuronal loss in Parkinson's disease: a neuroanatomical-biochemical perspective.
Hornykiewicz O
Clin Neurol Neurosurg; 1992; 94 Suppl():S9-11. PubMed ID: 1320533
[TBL] [Abstract][Full Text] [Related]
9. Effects of eldepryl on glial cell proliferation and activation in the substantia nigra and striatum in a rat model of Parkinson's disease.
Liu B; Lv C; Zhang J; Liu Y; Sun J; Cheng X; Mao W; Ma Y; Li S
Neurol Res; 2017 May; 39(5):459-467. PubMed ID: 28276259
[TBL] [Abstract][Full Text] [Related]
10. Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's 250th birthday.
Lees AJ
Mov Disord; 2007 Sep; 22 Suppl 17():S327-34. PubMed ID: 18175393
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of nigral cell death in Parkinson's disease.
Przedborski S
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S3-7. PubMed ID: 15885625
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
14. Does oxidative stress participate in nerve cell death in Parkinson's disease?
Hirsch EC
Eur Neurol; 1993; 33 Suppl 1():52-9. PubMed ID: 8375433
[TBL] [Abstract][Full Text] [Related]
15. The effects of striatal silent lacunar infarction on the substantia nigra and movement disorders in Parkinson's disease: A follow-up study.
Zhang G; Zhang C; Zhang Y; Wang Y; Nie K; Zhang B; Xie H; Lu J; Wang L
Parkinsonism Relat Disord; 2017 Oct; 43():33-37. PubMed ID: 28688982
[TBL] [Abstract][Full Text] [Related]
16. Native DIGE proteomic analysis of mitochondria from substantia nigra and striatum during neuronal degeneration and its compensation in an animal model of early Parkinson's disease.
Kuter K; Kratochwil M; Marx SH; Hartwig S; Lehr S; Sugawa MD; Dencher NA
Arch Physiol Biochem; 2016 Dec; 122(5):238-256. PubMed ID: 27467289
[TBL] [Abstract][Full Text] [Related]
17. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?
Mouatt-Prigent A; Karlsson JO; Agid Y; Hirsch EC
Neuroscience; 1996 Aug; 73(4):979-87. PubMed ID: 8809817
[TBL] [Abstract][Full Text] [Related]
18. PET Imaging of Serotonin Transporters With 4-[(18)F]-ADAM in a Parkinsonian Rat Model With Porcine Neural Xenografts.
Chiu CH; Li IH; Weng SJ; Huang YS; Wu SC; Chou TK; Huang WS; Liao MH; Shiue CY; Cheng CY; Ma KH
Cell Transplant; 2016; 25(2):301-11. PubMed ID: 25994923
[TBL] [Abstract][Full Text] [Related]
19. Cell transplantation in the damaged adult brain.
Jaber M; Benoit-Marand M; Prestoz L; Gaillard A
Rev Neurol (Paris); 2013 Nov; 169(11):838-43. PubMed ID: 24112517
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic function and progression of Parkinson's disease: PET findings.
Biju G; de la Fuente-Fernández R
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S38-40. PubMed ID: 20123555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
